Standard Glass Lining Technology Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹52(37.14%)
Premium (ELP)
Standard Glass Lining Technology Limited's successfully completed its Initial Public Offering and commenced trading on Jan 13, 2025 at the NSE, BSE exchange. The company raised 2,92,89,367 Shares through this public offering, comprising 1,50,00,000 Shares in fresh capital and ₹200.05 Cr through the Offer for Sale mechanism.
The IPO was priced within the band of ₹133 to ₹140, with minimum application lots of 107 shares. The offering attracted significant investor interest during its subscription period from Jan 06, 2025 to Jan 08, 2025.
Share allotment was finalized on Jan 09, 2025, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Founded in September 2012, Standard Glass Lining Technology Limited is a reliable Indian manufacturer of engineering equipment for the pharmaceutical and chemical sectors. The company offers complete in-house solutions, from design and manufacturing to installation and operational support. Its product range includes reaction systems, storage and drying systems, and plant engineering services, built using high-quality materials like glass-lined steel, stainless steel, and nickel alloys. With eight manufacturing units in Hyderabad and sales offices in Vadodara, Ankleshwar, Mumbai, and Visakhapatnam, the company serves clients such as Aurobindo Pharma, Cadila Pharmaceuticals, Laurus Labs, and Natco Pharma. Supported by 460 full-time employees and 731 contract workers as of September 30, 2024, Standard Glass Lining continues to deliver innovative and dependable engineering solutions across India.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Expertise in Specialized Equipment: We create high-quality, custom-engineered equipment for the pharmaceutical and chemical industries, supporting every stage of the manufacturing process.
- State-of-the-Art Facilities: Our strategically located units in Hyderabad are equipped with advanced technology for seamless and efficient production.
- Complete Turnkey Solutions: From design and engineering to installation and operational support, we offer end-to-end services with a focus on customer needs and innovative solutions.
- Location Dependence: Since all our manufacturing facilities are in Telangana, our operations could be affected by local disruptions, such as economic, political, or natural events.
- Skilled Workforce Reliance: We depend on a highly skilled team, so workforce shortages or retention challenges could impact our work and productivity.
- Supplier Dependence: Relying on a few key suppliers for raw materials means any supply issues could delay production and affect our client relationships and results.
- Nageswara Rao Kandula
- Kandula Krishna Veni
- Kandula Ramakrishna
- Venkata Mohana Rao Katragadda
- Kudaravalli Punna Rao
- M/s S2 Engineering Services
Standard Glass Lining Technology Limited
Kfin Technologies Limited